What the Label and the Risk Plan Are For

Part of Pharmacovigilance and Drug Safety (PV) Training: Signal Detection and Risk.

About 2 minutes. Free, in your language, no account needed.

The point of all of it

Every case processed, every expedited report, every aggregate report and every signal exists to do one thing: make sure the people prescribing and taking a medicine know what is actually known about it, and that the known risks are managed.

The product information is where that knowledge ends up.

Risk management planning

A Risk Management Plan sets out what is known about a product's safety, what is not known, and what is being done about both.

Important identified risks. Established, in the label, characterized.

Important potential risks. Suspected, not established, under investigation.

Missing information. Populations or uses where there is little data. Pregnancy, children, the very elderly, severe renal impairment.

Naming missing information explicitly is one of the more honest features of the framework. It records what nobody knows, rather than leaving the absence to be inferred.

Risk minimization

Routine measures: the label, the packaging, the pack size, the legal status.

Additional measures, where routine ones are judged insufficient: educational materials, a controlled access program, a pregnancy prevention program, a registry.

Additional measures are a burden on patients and prescribers, so they are used where the risk justifies it, and their effectiveness is meant to be measured rather than assumed.

Where this course ends

The individual case you process on an ordinary Tuesday is the unit all of this is built from. It travels a long way from your desk, and most of the mechanisms above will not work if the case was built carelessly.

That is the argument for the discipline this course describes, and it is the whole of it.